Powerful AI tools that redefine what’s possible.

An agentic AI system that combines diagnostics, risk prediction, and research insights into a unified interface to enhance decision-making and care continuity for liver disease patients.

A multi-modal digital liver platform that integrates omics, imaging, EHR, and clinical data for AI-driven diagnosis, risk prediction, and biomarker discovery.

An automated AI engine that mines and analyzes large-scale public RNA-seq datasets to identify early-stage biomarkers for liver disease.

An AI assessment tool that evaluates fatty liver disease risk through a personalized questionnaire.
Watch demo

Assesses fatty liver (hepatic steatosis) risk across 3 AI-based diagnostic tiers: Basic (anthropometric data), Intermediate (vitals + serum markers), Comprehensive (liver function tests). Fully scalable for primary to tertiary care.

LivAid is a 'Bio Marker Validator' provides expert information on liver conditions, particularly MASLD and MASH, by integrating advanced language understanding with knowledge graphs and retrieval.
Watch demo

AI-powered diagnostic tool that improves diagnostic accuracy and clinician workflow. Supports liver imaging (CT, ultrasound, histopathology), ophthalmology (fundus images), and pulmonary screening (X-ray).

Integrates image-based diagnostics with personalized lifestyle and risk questionnaires to assess four major cancers primarily affecting women: breast, ovarian, cervical, and endometrial.

A comprehensive AI platform—integrating lifestyle, biometric, and lab data—for predicting population and individual risk of diabetes and
hypertension.